Related Experiment Video
Updated: Jan 22, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
MicroRNA-128/homeobox B8 axis regulates ovarian cancer cell progression
Rui Li1, Lingling Gong1, Pin Li1
1Department of Obstetrics and Gynecology, Affiliated Hospital of Hebei University, Baoding, China.
Abstract:
MicroRNA-128 (miR-128) has been found to be dysregulated and might function as a tumour suppressor in various cancers, including ovarian cancer. However, the underlying mechanism of miR-128 in ovarian cancer has not been fully understood. The miR-128 and homeobox B8 (HOXB8) levels in clinical samples and cultured cell lines were measured using qRT-PCR and/or Western blot analysis. Cell proliferation was assessed using Cell Counting Kit-8 assay. Cell apoptosis was determined using flow cytometry. The association between miR-128 and HOXB8 was confirmed using dual-luciferase reporter assay. Results showed that decreased miR-128 expression and increased HOXB8 expression were observed in ovarian cancer tissues and cell lines. Transfection with miR-128 mimics suppressed the cell proliferation and enhanced paclitaxel sensitivity in ovarian cancer cell lines. miR-128 directly targeted HOXB8 in ovarian cancer cell lines. Knockdown of HOXB8 abolished the effects of miR-128 inhibitor on ovarian cancer cell proliferation and paclitaxel sensitivity. Summarily, miR-128 displayed a tumour suppressor role in ovarian cancer via targeting HOXB8. It is supposed that miR-128 might be effective for targeting therapy for ovarian cancer.
Insights
MicroRNA-128 (miR-128) acts as a tumor suppressor in ovarian cancer by targeting HOXB8. This finding suggests miR-128 could be a potential therapeutic target for ovarian cancer treatment.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNA-128 (miR-128) is implicated as a tumor suppressor in various cancers, but its specific mechanism in ovarian cancer remains unclear.
- Dysregulation of miR-128 and its targets is a key area of investigation in ovarian cancer pathogenesis.
Purpose of the Study:
- To elucidate the functional role and molecular mechanism of miR-128 in ovarian cancer.
- To investigate the regulatory relationship between miR-128 and homeobox B8 (HOXB8) in ovarian cancer cells.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and Western blot analysis to measure miR-128 and HOXB8 expression.
- Cell Counting Kit-8 assay for cell proliferation and flow cytometry for apoptosis analysis.
- Dual-luciferase reporter assay to confirm direct targeting of HOXB8 by miR-128.
Main Results:
- Ovarian cancer tissues and cell lines exhibited decreased miR-128 expression and increased HOXB8 expression.
- Overexpression of miR-128 suppressed ovarian cancer cell proliferation and enhanced sensitivity to paclitaxel.
- miR-128 was confirmed to directly target HOXB8, and HOXB8 knockdown reversed the effects of miR-128 inhibition.
Conclusions:
- miR-128 functions as a tumor suppressor in ovarian cancer by directly targeting HOXB8.
- The miR-128/HOXB8 axis represents a potential therapeutic strategy for ovarian cancer targeting.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hypothalamic-Pituitary Axis
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

